# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Paragraph 8: Amendment of Schedule 4 (periodic fees for licences)


In Schedule 4, in paragraph 1, in the definition of “limited use drug” for “which is in respect of an orphan medicinal product” substitute “in respect of which an orphan marketing authorisation has been granted”.

---
Source: https://www.legislation.gov.uk/ukdsi/2019/9780111179185/schedule/1/paragraph/8 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2019/schedule-1/paragraph-8
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.